Correlation Between Chemcon Speciality and Tribhovandas Bhimji

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chemcon Speciality and Tribhovandas Bhimji at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chemcon Speciality and Tribhovandas Bhimji into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chemcon Speciality Chemicals and Tribhovandas Bhimji Zaveri, you can compare the effects of market volatilities on Chemcon Speciality and Tribhovandas Bhimji and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chemcon Speciality with a short position of Tribhovandas Bhimji. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chemcon Speciality and Tribhovandas Bhimji.

Diversification Opportunities for Chemcon Speciality and Tribhovandas Bhimji

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Chemcon and Tribhovandas is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Chemcon Speciality Chemicals and Tribhovandas Bhimji Zaveri in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tribhovandas Bhimji and Chemcon Speciality is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chemcon Speciality Chemicals are associated (or correlated) with Tribhovandas Bhimji. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tribhovandas Bhimji has no effect on the direction of Chemcon Speciality i.e., Chemcon Speciality and Tribhovandas Bhimji go up and down completely randomly.

Pair Corralation between Chemcon Speciality and Tribhovandas Bhimji

Assuming the 90 days trading horizon Chemcon Speciality Chemicals is expected to generate 0.47 times more return on investment than Tribhovandas Bhimji. However, Chemcon Speciality Chemicals is 2.15 times less risky than Tribhovandas Bhimji. It trades about -0.2 of its potential returns per unit of risk. Tribhovandas Bhimji Zaveri is currently generating about -0.26 per unit of risk. If you would invest  24,415  in Chemcon Speciality Chemicals on August 25, 2024 and sell it today you would lose (1,537) from holding Chemcon Speciality Chemicals or give up 6.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Chemcon Speciality Chemicals  vs.  Tribhovandas Bhimji Zaveri

 Performance 
       Timeline  
Chemcon Speciality 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chemcon Speciality Chemicals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Tribhovandas Bhimji 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Tribhovandas Bhimji Zaveri are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Tribhovandas Bhimji exhibited solid returns over the last few months and may actually be approaching a breakup point.

Chemcon Speciality and Tribhovandas Bhimji Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chemcon Speciality and Tribhovandas Bhimji

The main advantage of trading using opposite Chemcon Speciality and Tribhovandas Bhimji positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chemcon Speciality position performs unexpectedly, Tribhovandas Bhimji can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tribhovandas Bhimji will offset losses from the drop in Tribhovandas Bhimji's long position.
The idea behind Chemcon Speciality Chemicals and Tribhovandas Bhimji Zaveri pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings